| 中文别名 |
替米沙坦;4-{[2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑-1-基]甲基}联苯基-2-羧酸;4'-[[2-丙基-4-甲基-6(1-甲基苯并咪唑-2-基)-苯并咪唑-1-基]甲基]-2-联苯羧酸;4′-[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑-1-基甲基]联苯基-2-羧酸;替米沙坦 4'-[(1,4'-二甲基-2'-丙基[2,6'-联-1氢-苯并咪唑]-1'-基)甲基]-[1,1'-联苯]-2-羧酸;4'-[[1,4'-二甲基-2'-丙基[2,6'-联-1H-苯并咪唑]-1'-甲基]-[1,1'-联苯基]-2-羧酸,二甲基乙基酯;泰米沙坦;2-(2H-苯并三唑)-5-正己氧基苯酚;4'-[[1,4'-二甲基-2'-丙基(2,6'-联-1H-苯并咪唑)-1'-甲基]-[1,1'-联苯基]-2-羧酸叔丁酯;4-[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑基甲基]联苯基-2-羧酸;Telmisartan 替米沙坦;氘代丁醇;替米沙;替米沙坦 EP标准品;替米沙坦 USP标准品;替米沙坦 标准品;替米沙坦峰鉴别 EP标准品;替米沙坦及其杂质标准品;替米沙坦系统适应性 EP标准品;盐酸坦索罗辛-D4;4'-[[2-丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)-苯并咪唑-1-基]甲基]-2-联苯羧酸;4'-[[4-甲基-6-(1-甲基-1H-苯并咪唑-2-基)-2-丙基-1H-苯并咪唑-1-基]甲基]联苯-2-羧酸;替米沙坦(对照品) |
| 英文别名 |
4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid;TU-199;TELMISARTAN;PRITOR;MICARDIS;BIBR 277;4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID;4'-[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID;3-methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl sulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene;4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid;4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid;替米沙坦;Kinzalmono;BIBR 277SE;Telmisattan;Targit;Telmisartan [INN];4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid;U5SYW473RQ;C33H30N4O2;2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]ph;s1738;TELMISARTAN (USP-RS);4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID;KS-1215;TELMISARTAN [ORANGE BOOK];NSC 759811;EN300-123532;4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid;SBI-0206733.P001;144701-48-4;TELMISARTAN [GREEN BOOK];AC-2013;TELMISARTAN (USP MONOGRAPH);BIBR-277 SE;NS00000398;ALBB-028954;BIBR-277SE;BRD-K73999723-001-02-2;DL-511;TELMISARTAN COMPONENT OF TWYNSTA;Telsite;4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid;HMS3393P16;Kinzal;Telmisartan Actavis;TELMISARTAN [EP IMPURITY];SPECTRUM1505261;AB07687;NCGC00095150-01;Telmisartan, European Pharmacopoeia (EP) Reference Standard;TELMISARTAN [EP MONOGRAPH];TELMISARTAN [EMA EPAR];HY-13955;4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid;Micardis (TN);Q733186;Telmisartan, United States Pharmacopeia (USP) Reference Standard;T2861;Telmisartan (JP17/USP/INN);4''-((1,4''-dimethyl-2''-propyl(2,6''-bi-1H-benzimidazol)-1''-yl)methyl)-(1,1''-biphenyl)-2-carboxylic acid;Telmisartan- Bio-X;HMS3715L17;ONDUARP COMPONENT TELMISARTAN;TELMISARTAN (MART.);TELMISARTAN COMPONENT OF MICARDISPLUS;Spectrum4_001261;TELMISARTAN (EP IMPURITY);MLS006011851;BIBR-277;TELMISARTAN [MI];MICARDISPLUS COMPONENT TELMISARTAN;TELMISARTAN (EP MONOGRAPH);TELMISARTAN [WHO-DD];4''-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid;4'-((1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOL-3'-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID;BIBR-277-SE;AB00639941-07;4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl][1,1''-biphenyl]-2-carboxylic acid;BCP0726000055;MLS000759432;HMS1922P07;NSC-759811;Spectrum5_001053;Kinzal/Pritor;BRD-K73999723-001-11-3;Telmisartan for peak identification, European Pharmacopoe... |
